MGMT and neoplasm: Lastly, there were no differences between infarct and control groups in tumor MGMT methylation status (11.1 vs. 14.6% methylated, p = 0.86), IDH mutation status (0 vs. 4.2% positive, p = 0.62), or proportion of subjects who underwent chemotherapy and/or radiotherapy.